N.I. Cherny, on behalf of the ESMO Guidelines Working Group, ESMO Clinical Practice Guidelines for the management of refractory symptoms at the end of life and the use of palliative sedation, „Annals of Oncology”, 25 Suppl 3, 2014, iii143–iii152, DOI: 10.1093/annonc/mdu238, PMID: 25210083(ang.).
N.I. Cherny, on behalf of the ESMO Guidelines Working Group, ESMO Clinical Practice Guidelines for the management of refractory symptoms at the end of life and the use of palliative sedation, „Annals of Oncology”, 25 Suppl 3, 2014, iii143–iii152, DOI: 10.1093/annonc/mdu238, PMID: 25210083(ang.).